Ontology highlight
ABSTRACT: Context
Cystic fibrosis (CF) transmembrane conductance (CFTR) dysfunction may play a role in CF-related bone disease (CFBD). Ivacaftor is a CFTR potentiator effective in improving pulmonary and nutritional outcomes in patients with the G551D-CFTR mutation. The effects of ivacaftor on bone health are unknown.Objective
To determine the impact of ivacaftor on bone density and microarchitecture in children and adults with CF.Design
Prospective observational multiple cohort study.Setting
Outpatient clinical research center within a tertiary academic medical center.Patients or other participants
Three cohorts of age-, race-, and gender-matched subjects were enrolled: 26 subjects (15 adults and 11 children) with CF and the G551D-CFTR mutation who were plann
SUBMITTER: Putman MS
PROVIDER: S-EPMC7947772 | biostudies-literature | 2021 Mar
REPOSITORIES: biostudies-literature